EG24749A - Microparticulate form of a tetrahydropyridin derivative. - Google Patents
Microparticulate form of a tetrahydropyridin derivative.Info
- Publication number
- EG24749A EG24749A EG138497A EG138497A EG24749A EG 24749 A EG24749 A EG 24749A EG 138497 A EG138497 A EG 138497A EG 138497 A EG138497 A EG 138497A EG 24749 A EG24749 A EG 24749A
- Authority
- EG
- Egypt
- Prior art keywords
- microparticulate form
- tetrahydropyridin
- derivative
- tetrahydropyridin derivative
- microparticulate
- Prior art date
Links
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical class C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615905A FR2757510B1 (fr) | 1996-12-23 | 1996-12-23 | Forme microparticulaire d'un derive de tetrahydropyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG24749A true EG24749A (en) | 2010-07-20 |
Family
ID=9499044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG138497A EG24749A (en) | 1996-12-23 | 1997-12-23 | Microparticulate form of a tetrahydropyridin derivative. |
Country Status (37)
| Country | Link |
|---|---|
| US (4) | US20020028247A1 (OSRAM) |
| EP (1) | EP0950051B1 (OSRAM) |
| JP (2) | JP4422214B2 (OSRAM) |
| KR (1) | KR100455797B1 (OSRAM) |
| CN (1) | CN1088698C (OSRAM) |
| AR (1) | AR009673A1 (OSRAM) |
| AT (1) | ATE250032T1 (OSRAM) |
| AU (1) | AU730302B2 (OSRAM) |
| BR (1) | BR9714177A (OSRAM) |
| CA (1) | CA2275593C (OSRAM) |
| CO (1) | CO4920213A1 (OSRAM) |
| CZ (1) | CZ294272B6 (OSRAM) |
| DE (1) | DE69724999T2 (OSRAM) |
| DK (1) | DK0950051T3 (OSRAM) |
| DZ (1) | DZ2386A1 (OSRAM) |
| EE (1) | EE04112B1 (OSRAM) |
| EG (1) | EG24749A (OSRAM) |
| ES (1) | ES2207758T3 (OSRAM) |
| FR (1) | FR2757510B1 (OSRAM) |
| HU (1) | HU224348B1 (OSRAM) |
| IL (1) | IL129937A (OSRAM) |
| IN (1) | IN186977B (OSRAM) |
| IS (1) | IS2064B (OSRAM) |
| MY (1) | MY126298A (OSRAM) |
| NO (1) | NO311569B1 (OSRAM) |
| NZ (1) | NZ336129A (OSRAM) |
| PL (1) | PL190098B1 (OSRAM) |
| PT (1) | PT950051E (OSRAM) |
| RU (1) | RU2193031C2 (OSRAM) |
| SI (1) | SI0950051T1 (OSRAM) |
| SK (1) | SK283917B6 (OSRAM) |
| TR (1) | TR199901362T2 (OSRAM) |
| TW (1) | TW534820B (OSRAM) |
| UA (1) | UA66776C2 (OSRAM) |
| WO (1) | WO1998028272A1 (OSRAM) |
| YU (1) | YU49427B (OSRAM) |
| ZA (1) | ZA9711579B (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2739852T3 (es) * | 2001-07-06 | 2020-02-04 | Veloxis Pharmaceuticals As | Aglomeración controlada |
| BE1015641A4 (fr) * | 2003-05-26 | 2005-07-05 | Mariani Jean Paul | Micronisation 70. |
| RU2472490C1 (ru) * | 2011-08-05 | 2013-01-20 | Открытое акционерное общество "Биосинтез" | Средство для лечения кожных гнойных инфекций, составы и способы получения |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US562883A (en) * | 1896-06-30 | Thill-coupling | ||
| FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
| US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| FR2639226B1 (fr) * | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
| FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| DK0625069T3 (da) * | 1992-10-26 | 1999-08-30 | Sanol Arznei Schwarz Gmbh | Fremgangsmåde til fremstilling af mikrokapsler |
| US5662883A (en) * | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
| US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
| US6489334B2 (en) * | 1996-12-23 | 2002-12-03 | Sanofi-Synthelabo | Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms |
| FR2763847B1 (fr) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 |
| US20020147216A1 (en) * | 2000-01-31 | 2002-10-10 | Yuhong Zhou | Mucin synthesis inhibitors |
-
1996
- 1996-12-23 FR FR9615905A patent/FR2757510B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-19 AR ARP970106030A patent/AR009673A1/es not_active Application Discontinuation
- 1997-12-22 DZ DZ970236A patent/DZ2386A1/xx active
- 1997-12-22 MY MYPI97006232A patent/MY126298A/en unknown
- 1997-12-23 TR TR1999/01362T patent/TR199901362T2/xx unknown
- 1997-12-23 WO PCT/FR1997/002394 patent/WO1998028272A1/fr active IP Right Grant
- 1997-12-23 US US09/331,514 patent/US20020028247A1/en not_active Abandoned
- 1997-12-23 KR KR10-1999-7005372A patent/KR100455797B1/ko not_active Expired - Fee Related
- 1997-12-23 IL IL12993797A patent/IL129937A/en not_active IP Right Cessation
- 1997-12-23 BR BR9714177-1A patent/BR9714177A/pt not_active Application Discontinuation
- 1997-12-23 PL PL97334276A patent/PL190098B1/pl not_active IP Right Cessation
- 1997-12-23 DK DK97952987T patent/DK0950051T3/da active
- 1997-12-23 CZ CZ19992291A patent/CZ294272B6/cs not_active IP Right Cessation
- 1997-12-23 AT AT97952987T patent/ATE250032T1/de active
- 1997-12-23 YU YU28899A patent/YU49427B/sh unknown
- 1997-12-23 EG EG138497A patent/EG24749A/xx active
- 1997-12-23 ZA ZA9711579A patent/ZA9711579B/xx unknown
- 1997-12-23 PT PT97952987T patent/PT950051E/pt unknown
- 1997-12-23 NZ NZ336129A patent/NZ336129A/xx not_active IP Right Cessation
- 1997-12-23 UA UA99063520A patent/UA66776C2/uk unknown
- 1997-12-23 AU AU56685/98A patent/AU730302B2/en not_active Ceased
- 1997-12-23 CN CN97180862A patent/CN1088698C/zh not_active Expired - Fee Related
- 1997-12-23 CA CA002275593A patent/CA2275593C/en not_active Expired - Fee Related
- 1997-12-23 DE DE69724999T patent/DE69724999T2/de not_active Expired - Lifetime
- 1997-12-23 EP EP97952987A patent/EP0950051B1/fr not_active Expired - Lifetime
- 1997-12-23 EE EEP199900263A patent/EE04112B1/xx not_active IP Right Cessation
- 1997-12-23 RU RU99116321/04A patent/RU2193031C2/ru not_active IP Right Cessation
- 1997-12-23 CO CO97074790A patent/CO4920213A1/es unknown
- 1997-12-23 SK SK829-99A patent/SK283917B6/sk not_active IP Right Cessation
- 1997-12-23 IN IN3767DE1997 patent/IN186977B/en unknown
- 1997-12-23 ES ES97952987T patent/ES2207758T3/es not_active Expired - Lifetime
- 1997-12-23 SI SI9730592T patent/SI0950051T1/xx unknown
- 1997-12-23 HU HU0001181A patent/HU224348B1/hu not_active IP Right Cessation
- 1997-12-23 JP JP52848298A patent/JP4422214B2/ja not_active Expired - Fee Related
-
1998
- 1998-01-21 TW TW086119619A patent/TW534820B/zh not_active IP Right Cessation
-
1999
- 1999-06-10 IS IS5077A patent/IS2064B/xx unknown
- 1999-06-22 NO NO19993077A patent/NO311569B1/no not_active IP Right Cessation
-
2002
- 2002-06-21 US US10/177,384 patent/US20020192292A1/en not_active Abandoned
-
2008
- 2008-06-13 US US12/138,582 patent/US20080255365A1/en not_active Abandoned
-
2009
- 2009-06-10 JP JP2009139083A patent/JP2009280581A/ja active Pending
- 2009-10-05 US US12/573,455 patent/US20100021541A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA961444B (en) | Pyrazolylbenzoyl derivatives. | |
| ZA977687B (en) | Substituted 6,5-hetero-bicyclic derivatives | |
| ZA977652B (en) | Substituted 6,6-hetero-bicyclic derivatives | |
| ZA9610858B (en) | Heteroclyclic compounds. | |
| ZA9711046B (en) | A novel compound form. | |
| AP9700954A0 (en) | 6-ohenylpyridyl-2-amine derivatives | |
| ZA97521B (en) | 19-Nor-pregnene derivatives. | |
| ZA972514B (en) | Pro-fragrance compound. | |
| ZA961449B (en) | Isoxazolylbenzoyl derivatives. | |
| IL126624A0 (en) | 3-descladinose-2, 3-anhydroerythromycin derivatives | |
| ZA969973B (en) | 2-thioxo-imidazolidin-4-one derivatives. | |
| ZA9711567B (en) | Compounds. | |
| ZA966048B (en) | Piperazine derivatives. | |
| AU5412798A (en) | Boiler | |
| ZA974953B (en) | Substituted pyrazolylpyrazole derivatives. | |
| ZA967741B (en) | Diarylalkenylamine derivatives. | |
| ZA975861B (en) | Bromotiacumicin compounds. | |
| ZA979725B (en) | Benzoaxozole derivative. | |
| ZA962821B (en) | 4-indolylpiperazinyl derivatives. | |
| ZA982436B (en) | Thiazolimine derivatives. | |
| ZA979781B (en) | Piperidine derivatives. | |
| ZA967357B (en) | Pyrazol-4-ylbenzoyl derivatives. | |
| EG24749A (en) | Microparticulate form of a tetrahydropyridin derivative. | |
| GB9622350D0 (en) | A damper | |
| ZA971167B (en) | Heterocyclyl-ergoline derivatives. |